Administered before infection, neither anti-CR1 (CD35) nor anti-CR3 (CD11b) affected the stimulatory capacity of monocytes, as evaluated by expression of CD86, CD40 and HLA-DR (data not shown). This evidence concerns the gene CR1 and infection.